# Lysophosphatidic Acid / Autotaxin Axis in Rheumatoid Lung Disease

> **NCT04284735** · NA · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 40 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** Quantitative ATX and LPA determination in plasma and sputum

## Key facts

- **NCT ID:** NCT04284735
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-03
- **Primary completion:** 2023-09
- **Final completion:** 2023-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04284735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04284735, "Lysophosphatidic Acid / Autotaxin Axis in Rheumatoid Lung Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04284735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*